1135-P: Real-World Effectiveness of a Blood Sugar Monitor and Companion Digital Therapeutic Combination in Improving Blood Glucose Levels among People with Diabetes in India
| العنوان: | 1135-P: Real-World Effectiveness of a Blood Sugar Monitor and Companion Digital Therapeutic Combination in Improving Blood Glucose Levels among People with Diabetes in India |
|---|---|
| المؤلفون: | Kirti Samudra, Abhishek Shah, Arjun Krishnakumar, Hemant Thacker, Tejal Lathia, Shilpa Joshi, Shehla Sajid Shaikh, Vinod Mattoo, Varsha Khatry, Rajeev Chawla |
| المصدر: | Diabetes. 68 |
| بيانات النشر: | American Diabetes Association, 2019. |
| سنة النشر: | 2019 |
| مصطلحات موضوعية: | medicine.medical_specialty, business.industry, Endocrinology, Diabetes and Metabolism, Significant difference, Blood sugar, medicine.disease, Random blood sugar, Diabetes mellitus, Internal medicine, Internal Medicine, Medicine, Fasting blood sugar, Health behavior, business, Blood Glucose Measurement |
| الوصف: | Background: The glycaemic control among people with diabetes in India is very poor. This study evaluated the effectiveness an iPDM (integrated personalised self-management) in changing health behavior to improve blood glucose levels. Methods: We used data from 883 participants (Average = 45.41 years; 72.71% male) who were using Accu-Chek® Active in conjunction with Wellthy Care™ digital therapeutic (WC DTx). The participants had to log the blood sugar values into the app manually. The WC DTx, developed in lines with AADE7 and RSSDI guidelines, includes skill-development through self-management education, and real time feedback and coaching through artificial intelligence (AI). Results: The users were on the combination of the Accu-Chek® Active blood sugar monitor and its companion WC DTx for an average of 30.87 days. There was a significant difference between the mean first and last logged fasting blood sugar (FBS) (149.33 mg/dl vs. 132.83 mg/dl, p = 0.0013) and random blood sugar (202.20 mg/dl vs. 169.79 mg/dl, p = 0.004) values. The average per-user app interaction was 8.12 instances. A total of 2184 blood glucose measurements were logged with an average of 2.29 measurements per user. There was a step-wise decrease in FBS as the app engagement increased. The lowest tertile of app engagers reduced their FBS by 20.99 mg/dl (p=0.086), the middle tertile of app engagers reduced their FBS 23.98 mg/dl (p=0.038), and those in the highest tertile of app engagers reduced their FBS by 25.36 mg/dl (p=0.016). The reduction in random blood sugar in the highest level of app engagers was significant (p=0.04) than the reduction in the lowest (p=0.144) and middle tertile (0.296) of app engagers. Conclusion: iPDM using Accu-Chek® Active along with Wellthy Care™ as a companion therapeutic, can help people with diabetes in India to improve self-management skills and overall blood sugar levels. Disclosure R. Chawla: None. A. Krishnakumar: Employee; Self; Wellthy Therapeutics. V. Khatry: Employee; Self; Roche Diabetes Care. A. Shah: Stock/Shareholder; Self; Wellthy Therapeutics. S. Joshi: None. S.S. Shaikh: None. T. Lathia: None. H. Thacker: None. K. Samudra: None. V. Mattoo: Consultant; Self; Wellthy Therapeutics. |
| تدمد: | 1939-327X 0012-1797 |
| DOI: | 10.2337/db19-1135-p |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::01f69e62b22a25b4d3e86e9df01c6b9c https://doi.org/10.2337/db19-1135-p |
| Rights: | CLOSED |
| رقم الانضمام: | edsair.doi...........01f69e62b22a25b4d3e86e9df01c6b9c |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 1939327X 00121797 |
|---|---|
| DOI: | 10.2337/db19-1135-p |